Status:
UNKNOWN
Fibroblast Growth Factor 23 and Hypertensive Disorder Complicating Pregnancy
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Hypertension, Pregnancy-Induced
Eligibility:
FEMALE
18-40 years
Brief Summary
Hypertensive disorder complicating pregnancy is a set of diseases of pregnancy coexisting with elevated blood pressure. The incidence of it is approximately 5-12%. Pregnancy-induced hypertension is a ...
Detailed Description
100 pregnant women with hypertensive disorder complicating pregnancy and 200 normal pregnant control women matched for maternal and gestational age were enrolled in the study. All the subjects underwe...
Eligibility Criteria
Inclusion
- Women with singleton pregnancy;
- Regular antenatal examination from the first trimester;
- Give birth in the university hospital (The 1st affiliated hospital of Sun Yat-sen University)
Exclusion
- Younger than 18 years old;
- Older than 40 years old;
- Multiple pregnancy;
- Complicated with other diseases such as hypertension, eclampsia, thyroid diseases, etc.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03821922
Start Date
December 1 2017
End Date
December 31 2023
Last Update
July 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obstetrics and Gynechology Department of the 1st affiliated hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510080